Literature DB >> 28317816

Hemophagocytic syndrome secondary to tuberculosis at 24-week gestation.

Alexandra Arteaga Fernández1, David Fernández de Velasco Pérez2, M C Jiménez Fournier1, J C Moreno Del Prado1, B Paraíso Torras1, M L Cañete Palomo1.   

Abstract

Hemophagocytic syndrome is a life-threatening disease characterized by the uncontrolled activation of macrophages, resulting in hemophagocytosis of blood cells in the bone marrow. A 20-year-old gravida at 23-week and 5-day gestation was admitted to hospital to evaluate fever up to 104°F of unknown origin, moderate cytopenia, and elevated levels of liver enzymes. Bone marrow biopsy confirmed hemophagocytic syndrome, and polymerase chain reaction came back positive for Mycobacterium tuberculosis. Supportive care and tuberculosis treatment resulted in clinical improvement. At 27 weeks and 5 days, premature rupture of the membranes occurred, and because of the high probability of reactivating the hemophagocytic syndrome, a cesarean section was performed at 29-week and 2-day gestation. Hemophagocytic syndrome is an uncommon disease which rarely appears during pregnancy. Early diagnosis and treatment can save both maternal and fetal lives.

Entities:  

Mesh:

Year:  2017        PMID: 28317816     DOI: 10.4103/ijmy.ijmy_14_17

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  3 in total

1.  Hemophagocytic lymphohistiocytosis in pregnancy evolving towards fulminant hepatitis.

Authors:  Camille Simard; Marie-Lou Tardif
Journal:  Obstet Med       Date:  2021-03-24

Review 2.  Management of hemophagocytic lymphohistiocytosis in pregnancy: Case series study and literature review.

Authors:  Congcong Liu; Jinsong Gao; Juntao Liu
Journal:  J Obstet Gynaecol Res       Date:  2022-01-02       Impact factor: 1.697

3.  Potential killer in the ICU-severe tuberculosis combined with hemophagocytic syndrome: A case series and literature review.

Authors:  Lulu Chen; Heng Weng; Hongyan Li; Jinbao Huang; Jianguang Pan; Yansheng Huang; Chenhui Ma
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.